The expression level of S100A10 mRNA and protein are significantly increased in human pancreatic tumors compared to normal ducts and nonductal stroma, and the knockdown of its expression could reduce surface plasminogen activation, invasiveness, and in vivo growth of pancreatic cancer cell lines 18. This evidence concerns the gene S100A10 and pancreatic neoplasm.